Fig. 3From: Estimation of relative biological effectiveness of 225Ac compared to 177Lu during [225Ac]Ac-PSMA and [177Lu]Lu-PSMA radiopharmaceutical therapy using TOPAS/TOPAS-nBio/MEDRASNormalized activity concentration per lesion and normalized number of source points per cell for 177LuBack to article page